SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000936392-06-000497
Filing Date
2006-05-10
Accepted
2006-05-10 17:26:30
Documents
11
Period of Report
2006-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a20103e10vq.htm 10-Q 407144
2 EXHIBIT 10.1 a20103exv10w1.htm EX-10.1 329461
3 EXHIBIT 10.2 a20103exv10w2.htm EX-10.2 81876
4 EXHIBIT 10.3 a20103exv10w3.htm EX-10.3 145885
5 EXHIBIT 15.1 a20103exv15w1.htm EX-15.1 2335
6 EXHIBIT 31.1 a20103exv31w1.htm EX-31.1 6817
7 EXHIBIT 31.2 a20103exv31w2.htm EX-31.2 6849
8 EXHIBIT 32.1 a20103exv32w1.htm EX-32.1 2455
9 EXHIBIT 32.2 a20103exv32w2.htm EX-32.2 2541
10 GRAPHIC a20103a2010300.gif GRAPHIC 17170
11 GRAPHIC a20103a2010301.gif GRAPHIC 1916
  Complete submission text file 0000936392-06-000497.txt   1013505
Mailing Address 11388 SORRENTO VALLEY ROAD SUITE 200 SAN DIEGO CA 92121
Business Address 11388 SORRENTO VALLEY ROAD STE 200 SAN DIEGO CA 92121 8586225200
AVANIR PHARMACEUTICALS (Filer) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: CA | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-15803 | Film No.: 06827515
SIC: 2834 Pharmaceutical Preparations